R
Rebekah M. Samsonraj Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
High Impact
Researcher
faculty
22 h-index
45 pubs
2,298 cited
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Rebekah M. Samsonraj's research focuses on mesenchymal stem/stromal cells (MSCs) and their applications in regenerative medicine and cellular therapy. Her work investigates the phenotypic and functional characteristics of various MSC sources, including bone marrow-derived and adipose-derived MSCs, as well as bovine MSCs. Recent publications explore the potential of MSC-derived extracellular vesicles for tissue repair and the impact of specific compounds, such as dasatinib and quercetin, on MSC characteristics. Additionally, her research examines the senescence-associated secretory phenotype of human bone marrow-derived MSCs and the phenotypic changes associated with long-term in vitro expansion.
Samsonraj's scholarship metrics include an h-index of 22, with 44 total publications and 2,261 total citations. She is recognized as a highly cited researcher. Her collaborative network includes Vitali Maldonado and I. Kade Karisma Ardana at the University of Arkansas at Fayetteville, and C. Lowry Barnes at the University of Arkansas for Medical Sciences, with whom she has co-authored multiple publications.
Metrics
- h-index: 22
- Publications: 45
- Citations: 2,298
Selected Publications
-
Validation of a Novel Genomic Biomarker of Mesenchymal Stem Cell Scalability and Implications of Genotype Status on Cellular Senescence Phenotypes (2025)
-
Examining the Effects of Quercetin on Phenotypic Characteristics of Human Mesenchymal Stem Cells (2025)
-
Phenotypic changes associated with continuous long term in vitro expansion of bone marrow-derived mesenchymal stem cells (2025)
-
Correction: Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells (2024)
-
Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells (2024)
-
Phenotypic and Functional Characterization of Bovine Adipose-Derived Mesenchymal Stromal Cells (2024)
-
Phenotypic and functional characterization of bovine adipose-derived mesenchymal stromal cells (2024)
-
Clinical utility of mesenchymal stem/stromal cells in regenerative medicine and cellular therapy (2023)
-
Versatility of mesenchymal stem cell-derived extracellular vesicles in tissue repair and regenerative applications (2022)
Collaboration Network
Top Collaborators
Vitali Maldonado
9 shared publications
In database
- Clinical utility of mesenchymal stem/stromal cells in regenerative medicine and cellular therapy
- Versatility of mesenchymal stem cell-derived extracellular vesicles in tissue repair and regenerative applications
- Phenotypic and Functional Characterization of Bovine Adipose-Derived Mesenchymal Stromal Cells
- Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
- Phenotypic changes associated with continuous long term in vitro expansion of bone marrow-derived mesenchymal stem cells
Showing 5 of 9 shared publications
Ryan M. Porter
University of Arkansas for Medical Sciences (US)
3 shared publications
- Versatility of mesenchymal stem cell-derived extracellular vesicles in tissue repair and regenerative applications
- Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
- Correction: Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
I Kade Karisma Ardana
University of Arkansas at Fayetteville (US)
3 shared publications
- Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
- Abstract 2341: Phenotypic and quality assessments of continuously expanded human bone marrow-derived mesenchymal stem cells from multiple donors
- Correction: Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
Ghazaleh Salmanian
2 shared publications
In database
- Versatility of mesenchymal stem cell-derived extracellular vesicles in tissue repair and regenerative applications
- Abstract 2341: Phenotypic and quality assessments of continuously expanded human bone marrow-derived mesenchymal stem cells from multiple donors
C. Lowry Barnes
University of Arkansas for Medical Sciences
2 shared publications
In database
- Clinical utility of mesenchymal stem/stromal cells in regenerative medicine and cellular therapy
- Phenotypic changes associated with continuous long term in vitro expansion of bone marrow-derived mesenchymal stem cells
Jeremy G Powell
University of Arkansas at Fayetteville
2 shared publications
In database
- Phenotypic and Functional Characterization of Bovine Adipose-Derived Mesenchymal Stromal Cells
- Phenotypic and functional characterization of bovine adipose-derived mesenchymal stromal cells
Sriya Pokharel
University of Arkansas at Fayetteville (US)
2 shared publications
- Phenotypic and Functional Characterization of Bovine Adipose-Derived Mesenchymal Stromal Cells
- Phenotypic and functional characterization of bovine adipose-derived mesenchymal stromal cells
D Heinrichs
University of Arkansas at Fayetteville (US)
2 shared publications
- Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
- Correction: Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
Esther Latres
2 shared publications
- An open‐label, multiple ascending dose trial of orally administered insulin Tregopil in patients with type 1 diabetes mellitus to evaluate its pharmacokinetics, pharmacodynamics, safety and tolerability
- Author response for "An open‐label, multiple ascending dose trial of orally administered insulin Tregopil in patients with type 1 diabetes mellitus to evaluate its pharmacokinetics, pharmacodynamics, safety and tolerability"
Leona Plum‐Mörschel
2 shared publications
- An open‐label, multiple ascending dose trial of orally administered insulin Tregopil in patients with type 1 diabetes mellitus to evaluate its pharmacokinetics, pharmacodynamics, safety and tolerability
- Author response for "An open‐label, multiple ascending dose trial of orally administered insulin Tregopil in patients with type 1 diabetes mellitus to evaluate its pharmacokinetics, pharmacodynamics, safety and tolerability"
Sundara Moorthi Nainar Murugesan
2 shared publications
- An open‐label, multiple ascending dose trial of orally administered insulin Tregopil in patients with type 1 diabetes mellitus to evaluate its pharmacokinetics, pharmacodynamics, safety and tolerability
- Author response for "An open‐label, multiple ascending dose trial of orally administered insulin Tregopil in patients with type 1 diabetes mellitus to evaluate its pharmacokinetics, pharmacodynamics, safety and tolerability"
Olivia Lou
2 shared publications
- An open‐label, multiple ascending dose trial of orally administered insulin Tregopil in patients with type 1 diabetes mellitus to evaluate its pharmacokinetics, pharmacodynamics, safety and tolerability
- Author response for "An open‐label, multiple ascending dose trial of orally administered insulin Tregopil in patients with type 1 diabetes mellitus to evaluate its pharmacokinetics, pharmacodynamics, safety and tolerability"
Jayanti Panda
2 shared publications
- An open‐label, multiple ascending dose trial of orally administered insulin Tregopil in patients with type 1 diabetes mellitus to evaluate its pharmacokinetics, pharmacodynamics, safety and tolerability
- Author response for "An open‐label, multiple ascending dose trial of orally administered insulin Tregopil in patients with type 1 diabetes mellitus to evaluate its pharmacokinetics, pharmacodynamics, safety and tolerability"
Ashwani Marwah
2 shared publications
- An open‐label, multiple ascending dose trial of orally administered insulin Tregopil in patients with type 1 diabetes mellitus to evaluate its pharmacokinetics, pharmacodynamics, safety and tolerability
- Author response for "An open‐label, multiple ascending dose trial of orally administered insulin Tregopil in patients with type 1 diabetes mellitus to evaluate its pharmacokinetics, pharmacodynamics, safety and tolerability"
C. L. Gopu
2 shared publications
- An open‐label, multiple ascending dose trial of orally administered insulin Tregopil in patients with type 1 diabetes mellitus to evaluate its pharmacokinetics, pharmacodynamics, safety and tolerability
- Author response for "An open‐label, multiple ascending dose trial of orally administered insulin Tregopil in patients with type 1 diabetes mellitus to evaluate its pharmacokinetics, pharmacodynamics, safety and tolerability"
Similar Researchers
Based on overlapping research topics
Vitali Maldonado
University of Arkansas at Fayetteville
Mesenchymal stem cell research
Tissue Engineering and Regenerative Medicine
Extracellular vesicles in disease
Younghye Song
University of Arkansas at Fayetteville
Mesenchymal stem cell research
Tissue Engineering and Regenerative Medicine
Extracellular vesicles in disease
Emma Smith
University of Arkansas at Fayetteville
Mesenchymal stem cell research
Tissue Engineering and Regenerative Medicine
Extracellular vesicles in disease
Zhiqiang Qin
University of Arkansas for Medical Sciences
Mesenchymal stem cell research
Tissue Engineering and Regenerative Medicine
Pharmacological Effects and Toxicity Studies
Ghazaleh Salmanian
University of Arkansas at Fayetteville
Mesenchymal stem cell research
Tissue Engineering and Regenerative Medicine
Extracellular vesicles in disease
Shemansky Jm
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Cancer-related molecular mechanisms research
Health Sciences Research and Education